The spectrum of tumors was similar irrespective of Myc-dose: most commonly hemangiosarcomas and thymic lymphomas; a small number of other tumor types including nodal and splenic lymphomas, germ cell tumors and adenocarcinomas, also occurred with lower frequency (Supplemental Table 1). This evidence concerns the gene MYC and angiosarcoma.